AKT1 and tuberculosis: The Western blot results suggest that TB treatment activates the TLR2/4-mediated MAPK/NF-κB signaling pathway through the MyD88-dependent pathway and activates the PI3K–AKT signaling pathway via TLR2, enhancing the immune response of RAW264.7 cells.